Log In
Print
BCIQ
Print
Print this Print this
 

2B3-101

  Manage Alerts
Collapse Summary General Information
Company to-BBB technologies B.V.
DescriptionLiposomal doxorubicin formulation conjugated with glutathione
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase I/II
IndicationBrain cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today